Latest Period
Q1 2026
Security Snapshot
Apyx Medical Corp - Common Stock (APYX) Institutional Ownership
CUSIP: 03837C106
13F Institutional Holders and Ownership History from Q4 2018 to Q1 2026
Institutions Reporting
66
Shares (Excl. Options)
20,740,616
Price
$3.69
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock
- Symbol
- APYX on Nasdaq
- Shares outstanding
- 41,168,218
- Price per share
- $3.81
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 20,740,616
- Total reported value
- $76,529,291
- % of total 13F portfolios
- 0%
- Share change
- +1,417,266
- Value change
- +$5,260,507
- Number of holders
- 66
- Price from insider filings
- $3.81
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- APYX - Apyx Medical Corp - Common Stock is tracked under CUSIP 03837C106.
- 66 institutions reported positions in Q1 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 59 to 66 between Q4 2025 and Q1 2026.
- Reported value moved from $66,915,648 to $76,529,291.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 66 institutions filings for Q1 2026.
Security key
03837C106
Latest holder period
Q1 2026
13F holders
66
13D/G owners
2
CIK / CUSIP context first
Open Q1 2026 holders
APYX full holder history
Apyx Medical Corp SEC filings
Apyx Medical Corp company facts
Apyx Medical Corp insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 03837C106:
Significant Owners of Apyx Medical Corp - Common Stock (APYX) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 10% | 0% | $14,394,468 | +$2,168,145 | 4,112,705 | +18% | Nantahala Capital Management, LLC | 31 Dec 2025 |
| ROYCE & ASSOCIATES LP | 6% | $8,550,622 | 2,443,035 | ROYCE & ASSOCIATES LP | 31 Dec 2025 |
As of 31 Mar 2026, 66 institutional investors reported holding 20,740,616 shares of Apyx Medical Corp - Common Stock (APYX). This represents 50% of the company’s total 41,168,218 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Apyx Medical Corp - Common Stock (APYX) together control 47% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 8.4% | 3,440,304 | -13% | 0.79% | $12,694,722 |
| Archon Capital Management LLC | 6.8% | 2,790,923 | -13% | 5.8% | $10,298,506 |
| ROYCE & ASSOCIATES LP | 6.3% | 2,611,224 | +6.9% | 0.1% | $9,635,417 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.8% | 1,555,272 | 0% | 0% | $5,738,954 |
| AIGH Capital Management LLC | 2.7% | 1,104,970 | 0% | 0.84% | $4,077,340 |
| Silverberg Bernstein Capital Management LLC | 2.5% | 1,041,070 | +0.78% | 2.1% | $3,841,548 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 2.2% | 901,398 | 0.53% | $3,326,159 | |
| COMMONWEALTH EQUITY SERVICES, LLC | 1.6% | 649,061 | -2.2% | 0% | $2,395,040 |
| HORIZON KINETICS ASSET MANAGEMENT LLC | 1.5% | 615,000 | 0% | 0.02% | $2,269,350 |
| SEI INVESTMENTS CO | 1.5% | 598,255 | +299% | 0% | $2,207,561 |
| BlackRock, Inc. | 1.3% | 527,748 | +3.3% | 0% | $1,947,390 |
| Taylor Frigon Capital Management LLC | 1% | 414,559 | -5.3% | 0.87% | $1,529,723 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.95% | 391,356 | +9.1% | 0% | $1,445,027 |
| RENAISSANCE TECHNOLOGIES LLC | 0.73% | 302,395 | +37% | 0% | $1,115,838 |
| Legato Capital Management LLC | 0.68% | 280,889 | 0.09% | $1,036,480 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.65% | 267,561 | +33% | 0% | $987,300 |
| MILLENNIUM MANAGEMENT LLC | 0.64% | 262,058 | +183% | 0% | $966,994 |
| Informed Momentum Co LLC | 0.6% | 246,435 | 0% | 0.11% | $909,345 |
| Huntleigh Advisors, Inc. | 0.6% | 245,920 | +4% | 0.16% | $907,445 |
| UBS Group AG | 0.56% | 231,345 | +16078% | 0% | $853,663 |
| Kingsview Wealth Management, LLC | 0.51% | 208,788 | +11% | 0.01% | $770,428 |
| VANGUARD FIDUCIARY TRUST CO | 0.49% | 202,681 | 0% | 0% | $747,893 |
| Caption Management, LLC | 0.45% | 185,751 | +16% | 0.03% | $685,421 |
| Hillsdale Investment Management Inc. | 0.42% | 174,300 | +84% | 0.02% | $643,167 |
| JANE STREET GROUP, LLC | 0.32% | 131,297 | -22% | 0% | $484,486 |
Institutional Holders of Apyx Medical Corp - Common Stock (APYX) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 20,740,616 | $76,529,291 | +$5,260,507 | $3.69 | 66 |
| 2025 Q4 | 19,119,856 | $66,915,648 | +$11,936,562 | $3.50 | 59 |
| 2025 Q3 | 15,737,051 | $33,674,427 | -$213,867 | $2.14 | 47 |
| 2025 Q2 | 15,811,115 | $35,574,319 | +$288,225 | $2.25 | 39 |
| 2025 Q1 | 15,792,917 | $21,635,134 | -$202,681 | $1.37 | 43 |
| 2024 Q4 | 15,925,107 | $25,160,336 | +$4,988,209 | $1.58 | 45 |
| 2024 Q3 | 12,800,031 | $15,871,504 | -$371,477 | $1.24 | 45 |
| 2024 Q2 | 13,089,462 | $17,538,939 | -$313,631 | $1.34 | 49 |
| 2024 Q1 | 13,334,937 | $18,134,845 | -$10,597,896 | $1.36 | 51 |
| 2023 Q4 | 17,452,702 | $45,730,029 | -$5,190,379 | $2.62 | 62 |
| 2023 Q3 | 18,328,200 | $58,651,537 | -$229,028 | $3.20 | 61 |
| 2023 Q2 | 18,770,221 | $94,412,555 | -$2,505,631 | $5.03 | 55 |
| 2023 Q1 | 20,085,109 | $58,156,535 | +$5,918,433 | $2.88 | 54 |
| 2022 Q4 | 18,191,340 | $42,568,844 | -$7,872,047 | $2.34 | 48 |
| 2022 Q3 | 20,926,665 | $93,963,141 | -$1,016,635 | $4.49 | 53 |
| 2022 Q2 | 21,031,854 | $123,244,150 | +$8,066,381 | $5.86 | 61 |
| 2022 Q1 | 19,582,685 | $127,931,812 | -$1,520,009 | $6.53 | 70 |
| 2021 Q4 | 19,106,864 | $244,910,256 | -$2,633,464 | $12.82 | 74 |
| 2021 Q3 | 18,881,855 | $261,278,213 | +$1,837,936 | $13.85 | 74 |
| 2021 Q2 | 19,074,530 | $196,570,403 | +$519,685 | $10.31 | 73 |
| 2021 Q1 | 18,975,246 | $183,295,913 | +$4,233,889 | $9.66 | 67 |
| 2020 Q4 | 18,563,287 | $133,715,214 | +$4,919,670 | $7.20 | 63 |
| 2020 Q3 | 17,818,092 | $83,924,627 | -$799,192 | $4.71 | 59 |
| 2020 Q2 | 18,132,429 | $100,699,990 | +$1,987,743 | $5.55 | 60 |
| 2020 Q1 | 17,698,113 | $63,538,783 | -$3,782,110 | $3.59 | 64 |
| 2019 Q4 | 18,252,816 | $154,427,344 | +$472,016 | $8.46 | 68 |
| 2019 Q3 | 17,769,394 | $120,273,837 | +$8,067,427 | $6.77 | 67 |
| 2019 Q2 | 17,318,462 | $116,360,053 | +$14,336,984 | $6.72 | 66 |
| 2019 Q1 | 15,330,673 | $96,737,645 | +$87,019,958 | $6.31 | 77 |
| 2018 Q4 | 924,973 | $5,994,000 | +$5,994,000 | $6.48 | 2 |